PLUS1
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last $ 4.62 ◊ 0.00 (0.00%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Amneal Pharmaceuticals Inc | AMRX | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.08 | -1.7% | 4.62 | 4.7799 | 4.60 | 4.70 | 4.70 | 16:04:39 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,636 | 641,084 | $ 4.67 | $ 2,993,254 | 4,193,780 | 2.27 - 14.79 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:07:39 | 1 | $ 4.74 | USD |
Amneal Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 1.38B | 299.10M | $ -20.92M | -0.16 | -1.90 | 298.06M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 4.96M | $ - | 0.00% | - | - |
Amneal Pharmaceuticals News
| Date | Time | Source | News Article |
|---|---|---|---|
| 1/24/2020 | 06:59 | Business Wire | Amneal to Report Fourth Quarter and Full Year 2019 Results.. |
| 12/26/2019 | 16:15 | Business Wire | Amneal Pharmaceuticals to Present at the 38th Annual J.P... |
| 12/16/2019 | 06:59 | Business Wire | Amneal Appoints Jeff George, John Kiely and Shlomo Yanai to.. |
| 12/12/2019 | 14:06 | Dow Jones News | Amneal Shares Up Nearly 50% on FDA Nod for NuvaRing Generic |
| 12/12/2019 | 08:04 | Dow Jones News | Amneal Gets FDA OK for First Generic of Merck's NuvaRing |
| 12/12/2019 | 06:59 | Business Wire | Amneal Receives Abbreviated New Drug Application Approval.. |
| 12/10/2019 | 06:59 | Business Wire | Amneal to Acquire Majority Interest in AvKARE, Enhancing.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AMRX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.32 | 5.42 | 4.40 | 4.85 | 980,758 | -0.70 | -13.16% |
| 1 Month | 4.98 | 5.68 | 4.345 | 4.88 | 1,594,386 | -0.36 | -7.23% |
| 3 Months | 2.51 | 5.79 | 2.43 | 4.44 | 3,196,381 | 2.11 | 84.06% |
| 6 Months | 3.83 | 5.79 | 2.27 | 3.85 | 2,390,196 | 0.79 | 20.63% |
| 1 Year | 12.17 | 14.79 | 2.27 | 5.42 | 1,834,040 | -7.55 | -62.04% |
| 3 Years | 17.00 | 24.48 | 2.27 | 9.40 | 1,528,393 | -12.38 | -72.82% |
| 5 Years | 17.00 | 24.48 | 2.27 | 9.40 | 1,528,393 | -12.38 | -72.82% |
Amneal Pharmaceuticals Description
| Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products and Specialty products. Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. It generates a majority of its revenue from the Generic business segment. |
